AlloStemSpine

N/A

Report date: 2024/06/20 14:17:01

Base Information

Drug NameAlloStemSpine
Drug Alias NameAlloStemCELZ-201CELZ-201-DDT
ClassificationCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Perinatal tissue-derived
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsLow Back PainDiabetes Mellitus, Type 1Intervertebral Disc Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCreative Medical Technology Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesCreative Medical Technology Holdings Inc
Inactive CompaniesN/A
Active IndicationsLow Back PainDiabetes Mellitus, Type 1Intervertebral Disc Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A